Rosana Michel

563 total citations
21 papers, 444 citations indexed

About

Rosana Michel is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Oncology. According to data from OpenAlex, Rosana Michel has authored 21 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Immunology and 5 papers in Oncology. Recurrent topics in Rosana Michel's work include Monoclonal and Polyclonal Antibodies Research (14 papers), Radiopharmaceutical Chemistry and Applications (11 papers) and Immunotherapy and Immune Responses (3 papers). Rosana Michel is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), Radiopharmaceutical Chemistry and Applications (11 papers) and Immunotherapy and Immune Responses (3 papers). Rosana Michel collaborates with scholars based in United States and Canada. Rosana Michel's co-authors include M. Jules Mattes, David M. Goldenberg, Chien‐Hsing Chang, Martin W. Brechbiel, Daniel J. Wallace, Diane L. Rossi, Edmund A. Rossi, Robert M. Grainger, Margaret S. Saha and Gary L. Griffiths and has published in prestigious journals such as Blood, Development and Cancer Research.

In The Last Decade

Rosana Michel

20 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosana Michel United States 13 278 135 123 112 56 21 444
Rhj Begent United Kingdom 13 287 1.0× 195 1.4× 95 0.8× 33 0.3× 32 0.6× 30 496
SJ Knox United States 12 387 1.4× 134 1.0× 142 1.2× 111 1.0× 138 2.5× 21 586
Diane Eggensperger United States 11 320 1.2× 153 1.1× 131 1.1× 118 1.1× 53 0.9× 13 513
Amy Haynes United States 4 355 1.3× 169 1.3× 160 1.3× 155 1.4× 54 1.0× 4 488
Diane Amox United States 8 171 0.6× 121 0.9× 88 0.7× 142 1.3× 75 1.3× 9 414
Shui‐on Leung United States 10 307 1.1× 164 1.2× 168 1.4× 131 1.2× 124 2.2× 28 472
Atsushi Doi Japan 12 337 1.2× 99 0.7× 118 1.0× 106 0.9× 41 0.7× 18 657
Evan Nair‐Gill United States 11 91 0.3× 129 1.0× 169 1.4× 106 0.9× 21 0.4× 17 415
Shani L. Frayo United States 11 286 1.0× 182 1.3× 121 1.0× 58 0.5× 70 1.3× 23 530
Geoffrey M. Boxer United Kingdom 15 276 1.0× 165 1.2× 112 0.9× 39 0.3× 22 0.4× 18 523

Countries citing papers authored by Rosana Michel

Since Specialization
Citations

This map shows the geographic impact of Rosana Michel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosana Michel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosana Michel more than expected).

Fields of papers citing papers by Rosana Michel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosana Michel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosana Michel. The network helps show where Rosana Michel may publish in the future.

Co-authorship network of co-authors of Rosana Michel

This figure shows the co-authorship network connecting the top 25 collaborators of Rosana Michel. A scholar is included among the top collaborators of Rosana Michel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosana Michel. Rosana Michel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rossi, Edmund A., David M. Goldenberg, Rosana Michel, et al.. (2013). Trogocytosis of multiple B-cell surface markers by CD22 targeting with epratuzumab. Blood. 122(17). 3020–3029. 88 indexed citations
2.
Chang, Chien‐Hsing, Pankaj Gupta, Rosana Michel, et al.. (2010). Ranpirnase (Frog RNase) Targeted with a Humanized, Internalizing, Anti–Trop-2 Antibody Has Potent Cytotoxicity against Diverse Epithelial Cancer Cells. Molecular Cancer Therapeutics. 9(8). 2276–2286. 43 indexed citations
3.
Mattes, M. Jules, Rosana Michel, David M. Goldenberg, & Robert M. Sharkey. (2009). Induction of Apoptosis by Cross-Linking Antibodies Bound to Human B-Lymphoma Cells: Expression of Annexin V Binding Sites on the Antibody Cap. Cancer Biotherapy and Radiopharmaceuticals. 24(2). 185–193. 8 indexed citations
4.
Michel, Rosana, Mones Abu‐Asab, Maria Tsokos, & M. Jules Mattes. (2006). Characterization of antibody-containing vesicles shed from B-lymphoma cell lines: exposure of annexin V binding sites. Leukemia & lymphoma. 47(11). 2388–2399. 2 indexed citations
5.
Michel, Rosana, et al.. (2005). 177Lu-antibody conjugates for single-cell kill of B-lymphoma cells in vitro and for therapy of micrometastases in vivo. Nuclear Medicine and Biology. 32(3). 269–278. 32 indexed citations
6.
Michel, Rosana, et al.. (2005). Therapy of Small Subcutaneous B-Lymphoma Xenografts with Antibodies Conjugated to Radionuclides Emitting Low-Energy Electrons. Clinical Cancer Research. 11(2). 777–786. 25 indexed citations
7.
Govindan, Serengulam V., Rosana Michel, Gary L. Griffiths, David M. Goldenberg, & M. Jules Mattes. (2005). Deferoxamine as a chelator for 67Ga in the preparation of antibody conjugates. Nuclear Medicine and Biology. 32(5). 513–519. 29 indexed citations
8.
Michel, Rosana, et al.. (2005). In vitrocytotoxicity of carcinoma cells with 111In-labeled antibodies to HER-2. Molecular Cancer Therapeutics. 4(6). 927–937. 16 indexed citations
9.
Michel, Rosana & M. Jules Mattes. (2004). Antibodies to CD20 and MHC class II antigen bound to B-lymphoma cells accumulate in shed cytoplasmic fragments. British Journal of Cancer. 91(8). 1500–1507. 4 indexed citations
10.
11.
Michel, Rosana, et al.. (2003). Experimental therapy of disseminated B-Cell lymphoma xenografts with 213Bi-labeled anti-CD74. Nuclear Medicine and Biology. 30(7). 715–723. 13 indexed citations
12.
Michel, Rosana, Martin W. Brechbiel, & M. Jules Mattes. (2003). A comparison of 4 radionuclides conjugated to antibodies for single-cell kill.. PubMed. 44(4). 632–40. 39 indexed citations
13.
Govindan, Serengulam V., et al.. (2002). Use of Galactosylated-Streptavidin as a Clearing Agent with 111 In-Labeled, Biotinylated Antibodies to Enhance Tumor/Non-Tumor Localization Ratios. Cancer Biotherapy and Radiopharmaceuticals. 17(3). 307–316. 5 indexed citations
14.
Michel, Rosana, et al.. (2002). Rapid blood clearance of injected mouse IgG2a in SCID mice. Cancer Immunology Immunotherapy. 51(10). 547–556. 14 indexed citations
15.
Michel, Rosana, et al.. (2002). Antibody localization to B-cell lymphoma xenografts in immunodeficient mice: importance of using residualizing radiolabels.. PubMed. 8(8). 2632–9. 20 indexed citations
16.
Michel, Rosana & M. Jules Mattes. (2002). Intracellular accumulation of the anti-CD20 antibody 1F5 in B-lymphoma cells.. PubMed. 8(8). 2701–13. 38 indexed citations
17.
Saha, Margaret S., et al.. (1993). A Xenopus homeobox gene defines dorsal-ventral domains in the developing brain. Development. 118(1). 193–202. 48 indexed citations
18.
Shustik, Chaim, Rosana Michel, & Jacob Karsh. (1988). Nonsecretory Myeloma: A Study on Hypoimmunoglobulinemia. Acta Haematologica. 80(3). 153–158. 1 indexed citations
19.
McGregor, I., et al.. (1972). [Precipitating antibodies in malaria. Results of a double Senegalese survey].. PubMed. 65(4). 542–9. 1 indexed citations
20.
Mattern, P, et al.. (1961). Immunochemical Studies on the B2-MacroglobuIins in Sera of Patients suffering from Trypanosoma gambiense Infections.. Ann. Inst. Pasteur. 101(3). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rhj Begent Breakdown of academic impact, for papers by SJ Knox Breakdown of academic impact, for papers by Diane Eggensperger Breakdown of academic impact, for papers by Amy Haynes Breakdown of academic impact, for papers by Diane Amox Breakdown of academic impact, for papers by Shui‐on Leung Breakdown of academic impact, for papers by Atsushi Doi Breakdown of academic impact, for papers by Evan Nair‐Gill Breakdown of academic impact, for papers by Shani L. Frayo Breakdown of academic impact, for papers by Geoffrey M. Boxer
Rankless by CCL
2026